These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
808 related articles for article (PubMed ID: 6119184)
1. [Acid anti-secretion therapy in gastric and duodenal ulcer]. Lattanzi A Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184 [No Abstract] [Full Text] [Related]
2. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer. Giacosa A; Cheli R; Molinari F; Parodi MC Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138 [TBL] [Abstract][Full Text] [Related]
3. [Which drug for peptic ulcer?]. Hameeteman W; Tytgat GN Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643 [No Abstract] [Full Text] [Related]
5. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial]. Simon B; Müller P; Dammann HG Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304 [TBL] [Abstract][Full Text] [Related]
6. New drugs. H2 receptor antagonists--cimetidine and ranitidine. Feely J; Wormsley KG Br Med J (Clin Res Ed); 1983 Feb; 286(6366):695-7. PubMed ID: 6130817 [No Abstract] [Full Text] [Related]
8. Famotidine in the USA: a review of efficacy studies. Gitnick G J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539 [TBL] [Abstract][Full Text] [Related]
9. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases]. Senfft U Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463 [No Abstract] [Full Text] [Related]
10. [Results of a controlled comparative study between cimetidine and pirenzepin in 60 patients with ulcera ventriculi or duodeni]. Mittelstaedt A; Zilly A; Verhoeven A; Mielenz H Fortschr Med; 1981 Nov; 99(42):1764-8. PubMed ID: 7030892 [No Abstract] [Full Text] [Related]
11. Pharmacologic options for the control of peptic ulcer disease. Levine JB Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108 [No Abstract] [Full Text] [Related]
12. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
13. Another look at peptic ulcer. Piper DW; Barr GD Aust Fam Physician; 1981 Aug; 10(8):636-40. PubMed ID: 6117272 [No Abstract] [Full Text] [Related]
14. [Clinical trials in the therapy of peptic ulcer. 3. Ambulatary therapy of uncomplicated duodenal ulcer with diverse anticholinergic agents]. Gütz HJ; Berndt H; Wolff G Dtsch Gesundheitsw; 1970 Mar; 25(12):533-6. PubMed ID: 5483689 [No Abstract] [Full Text] [Related]
15. New drugs for peptic ulcer. Br Med J; 1980 Jul; 281(6233):95-6. PubMed ID: 6107146 [No Abstract] [Full Text] [Related]
18. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer. Skrodzka D; Gabryelewicz A Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490 [TBL] [Abstract][Full Text] [Related]
19. [Peptic ulcer: current therapy]. Pieragnoli E G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387 [No Abstract] [Full Text] [Related]
20. Pirenzepine in long-term therapy for duodenal ulcer. Capria A; Bresci G; Polloni A; Rindi G; Geloni M; Del Tacca M Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):422-4. PubMed ID: 6688799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]